Canton Hathaway’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $921K | Hold |
2,271
| – | – | 0.19% | 60 |
|
|
2025
Q1 | $1.13M | Buy |
2,271
+1,200
| +112% | +$597K | 0.23% | 49 |
|
|
2024
Q4 | $557K | Hold |
1,071
| – | – | 0.14% | 57 |
|
|
2024
Q3 | $662K | Hold |
1,071
| – | – | 0.17% | 54 |
|
|
2024
Q2 | $592K | Hold |
1,071
| – | – | 0.16% | 57 |
|
|
2024
Q1 | $622K | Hold |
1,071
| – | – | 0.17% | 54 |
|
|
2023
Q4 | $568K | Hold |
1,071
| – | – | 0.17% | 54 |
|
|
2023
Q3 | $542K | Sell |
1,071
-21
| -2% | -$10.6K | 0.17% | 53 |
|
|
2023
Q2 | $570K | Hold |
1,092
| – | – | 0.18% | 52 |
|
|
2023
Q1 | $629K | Hold |
1,092
| – | – | 0.21% | 50 |
|
|
2022
Q4 | $601K | Hold |
1,092
| – | – | 0.21% | 52 |
|
|
2022
Q3 | $554K | Hold |
1,092
| – | – | 0.2% | 60 |
|
|
2022
Q2 | $593K | Hold |
1,092
| – | – | 0.21% | 59 |
|
|
2022
Q1 | $645K | Sell |
1,092
-83
| -7% | -$49K | 0.18% | 62 |
|
|
2021
Q4 | $784K | Hold |
1,175
| – | – | 0.21% | 61 |
|
|
2021
Q3 | $671K | Buy |
1,175
+98
| +9% | +$56K | 0.19% | 69 |
|
|
2021
Q2 | $543K | Buy |
1,077
+166
| +18% | +$83.7K | 0.16% | 70 |
|
|
2021
Q1 | $416K | Buy |
911
+70
| +8% | +$32K | 0.13% | 78 |
|
|
2020
Q4 | $392K | Buy |
841
+40
| +5% | +$18.6K | 0.13% | 80 |
|
|
2020
Q3 | $354K | Hold |
801
| – | – | 0.15% | 64 |
|
|
2020
Q2 | $290K | Hold |
801
| – | – | 0.19% | 59 |
|
|
2020
Q1 | $227K | Sell |
801
-245
| -23% | -$69.4K | 0.16% | 57 |
|
|
2019
Q4 | $340K | Buy |
1,046
+150
| +17% | +$48.8K | 0.17% | 63 |
|
|
2019
Q3 | $261K | Buy |
896
+83
| +10% | +$24.2K | 0.14% | 71 |
|
|
2019
Q2 | $239K | Sell |
813
-340
| -29% | -$100K | 0.13% | 75 |
|
|
2019
Q1 | $315K | Buy |
1,153
+663
| +135% | +$181K | 0.18% | 56 |
|
|
2018
Q4 | $110K | Buy |
490
+235
| +92% | +$52.8K | 0.07% | 87 |
|
|
2018
Q3 | $62K | Buy |
+255
| New | +$62K | 0.04% | 92 |
|